The dog as model for chemotherapy of the Chagas' disease

Acta Tropica

Volumn 84, Issue 1, 2002, Pages 9-17

  Guedes, Paulo Marcos Da Matta ^a   Veloso, Vanja Maria ^a   Tafuri, Washington Luiz ^a   Galvão, Lúcia Maria Da Cunha ^b   Carneiro, Cláudia Martins ^a   Lana, Marta De ^a   Chiari, Egler ^b   Ataide Soares, Killarney ^a   Bahia, Maria Terezinha ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Canine experimental model; Chagas' disease; Chemotherapy; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE;

CANID; CHAGAS DISEASE; DISEASE CONTROL; EXPERIMENTAL STUDY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CULTURE; BLOOD EXAMINATION; CHAGAS DISEASE; CHEMOTHERAPY; CONTROLLED STUDY; CONVALESCENCE; DEATH; DISEASE MODEL; DOG; DRUG SENSITIVITY; EXPERIMENTAL INFECTION; FEMALE; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; SEROLOGY; TRYPANOSOMA CRUZI;

ADMINISTRATION, ORAL; ANIMALS; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; DOGS; DRUG RESISTANCE; FEMALE; MALE; NITROIMIDAZOLES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

ANIMALIA; CANIS FAMILIARIS; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0036801056     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(02)00139-0     Document Type: Article

References (38)

1. Andrade A.L.S.S., Zicker F., Oliveira M.R., Silva A.S., Luquetti A., Travassos L.R., Almeida S.S., Andrade J.C., Martelli C.M. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. The Lancet. 348:1996;1407-1413.
2. Andrade S.G., Magalhães J.B., Pontes A.L. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi of different types. Bull. WHO. 63:1985;721-726.
3. Andrade S.G., Stocker-Guerret S., Pimentel A.S., Grimaud J.A. Reversibility of cardiac fibrosis in mice chronically infected with Trypanosoma cruzi, under specific chemotherapy. Mem. Inst. Oswaldo Cruz. 86:1991;187-200.
4. Andrade S.G., Rassi A., Magalhães J.B., Filho F.F., Luquetti A.O. Specific chemotherapy of Chagas' disease: a comparison between the response in patients and experimental animals inoculated with the same strain. Trans. R. Soc. Trop. Med. Hyg. 86:1992;624-626.
5. Andrade Z.A., Andrade S.G. A patologia da doença de Chagas experimental no cão. Mem. Inst. Oswaldo Cruz. 75:1980;77-95.
6. Andrade Z.A. The canine model of Chagas' disease. Mem. Inst. Oswaldo Cruz. 79:1984;77-83.
7. Ávila H.A., Sigman D.S., Cohen L.M., Millikan R.C., Simpson L. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolation from whole blood lysates: diagnosis of chronic Chagas' disease. Mol. Biochem. Parasitol. 40:1991;211-222.
8. Ávila H.A., Gonçalves A.M., Nehme N.C., Morel C.M., Simpson L. Schizodeme analysis of Trypanosoma cruzi stocks from South and Central America by analysis of PCR-amplified minicircle variable region sequences. Mol. Biochem. Parasitol. 42:1990;175-187.
9. Bahia-Oliveira L.M.G., Gomes J.A.S., Cançado J.R., Ferrari T.C., Lemos E.M., Luz Z.M.P., Moreira M.C., Gazzinelli G., Corrêa-Oliveira R. Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago. J. Infect. Dis. 182:2000;634-638.
10. Braga M.S., Lauria-Pires L., Argañaraz E.R., Nascimento R.J., Teixeira A.R.L. Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives. Rev. Inst. Med. Trop. São Paulo. 42:2000;157-161.
11. Britto C., Cardoso M.A., Wincker P., Morel C.M.A. Simple protocol for cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in polymerase chain reaction (PCR) based diagnosis of chronic Chagas' disease. Mem. Inst. Oswaldo Cruz. 88:1993;171-172.
12. Britto C., Cardoso M.A., Monteiro-Vanni C.M., Hasslocher-Moreno A., Xavier S.S., Oelemann W., Santoro A., Pirmez C., Wincker P. Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation. Parasitology. 110:1995;241-247.
13. Cançado J.R. Evolution of knowledge on the etiological diagnosis of chagasic infection. Mem. Inst. Oswaldo Cruz. 94:1999;283-284.
14. Chiari E., Dias J.C.P., Lana M., Chiari C.A. Hemocultures for the parasitological diagnosis of human chronic Chagas' disease. Rev. Soc. Bras. Med. Trop. 22:1989;19-23.
15. Fabbro de Suasnábar D., Arias E., Streiger M., Piacenza M., Ingaramo M., Del Barco M., Amicone N. Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated chronic chagasic patients. Rev. Inst. Med. Trop. São Paulo. 42:2000;99-109.
16. 3H mice infected with Trypanosoma cruzi. J. Trop. Med. Hyg. 13:1964;272-280.
17. Ferreira H.O. Tratamento da forma indeterminada da doença de Chagas com nifurtimox e benznidazol. Rev. Soc. Bras. Med. Trop. 23:1990;209-211.
18. Filardi L.S., Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas' disease. Trans. R. Soc. Med. Hyg. 81:1987;755-759.
19. Galvão L.M.C., Nunes R.M.B., Cançado J.R., Brener Z., Krettli A.U. Lytic antibody titre as a means of assessing cure after treatment of Chagas' disease. Trans. R. Trop. Med. Hyg. 87:1993;220-223.
20. Gomes M.L., Macedo A.M., Vago A.R., Pena S.D.J., Galvão L.M.C., Chiari E. Trypanosoma cruzi: Optimization of polymerase chain reaction for detection in human blood. Exp. Parasitol. 88:1998;28-33.
21. Krettli A.U., Weisz-Carrington P., Nussenzweig R.S. Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice, strain differences in susceptibility to complement-mediated lysis. Clin. Exp. Immunol. 37:1979;416-423.
22. Krettli A.U., Cançado J.R., Brener Z. Criterion of cure of human Chagas' disease after specific chemotherapy: recent advances. Mem. Inst. Oswaldo Cruz. 79:1984;157-164.
23. Lana M., Chiari C.A. Caracterização biológica comparativa das cepas Berenice-62 e Berenice-78 de Trypanosoma cruzi, isoladas da mesma paciente em diferentes períodos. Mem. Inst. Oswaldo Cruz. 81:1986;247-253.
24. Lana M., Chiari E., Tafuri W.L. Experimental Chagas' disease in dogs. Mem. Inst. Oswaldo Cruz. 87:1992;59-71.
25. Luquetti A.O., Rassi A. Testes sorológicos e controle pós-terapêutico. Rev. Soc. Bras. Med. Trop. 32:1999;86.
26. Revollo S., Oury B., Laurent J.P., Barnabé C., Quesney V., Carriére V., Noel S., Tibayrenc M. Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Exp. Parasitol. 89:1998;30-39.
27. Santos F.R., Pena S.D.J., Epplen J.T. Genetic and population study of a Y-linked tetranucleotide repeat DNA polymorphism with a simple non-isotopic technique. Hum. Genet. 90:1993;655-656.
28. Shikanai-Yasuda M.A., Lopes M.H., Tolezano J.E., Umezawa E., Amato Neto V., Barret A.C., Higaki Y., Moreira A.A., Funayania G., Barone A.A. Acute Chagas' disease: transmission routes, clinical aspects and response to specific therapy in diagnosed cases in an urban center. Rev. Inst. Med. Trop. São Paulo. 32:1990;16-27.
29. Silva L.H.P., Nussenzweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clin. Biol. 20:1953;191-203.
30. Silveira C.A.N., Castilho E., Castro C. Avaliação do tratamento específico para o Trypanosoma cruzi em crianças, na evolução da fase indeterminada. Rev. Soc. Bras. Med. Trop. São Paulo. 33:2000;191-196.
31. Sosa Estani S., Segura E.L., Ruiz A.M., Velazquez E., Porcel B.M., Yampotis C. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am. J. Trop. Med. Hyg. 59:1998;526-529.
32. Toledo M.J.O., Guilherme A.L.F., Silva J.C., Gasperi M.V., Mendes A.P., Gomes M.L., Araújo S.M. Trypanosoma cruzi: chemotherapy with benznidazole in mice inoculated with strains from Paraná state and from different endemic areas of Brazil. Rev. Inst. Med. Trop. São Paulo. 39:1997;283-290.
33. Toledo M.J.O., Lana M., Bahia M.T., Carneiro C.M., Alves C.F., Martins H.R., Tibayrenc M., Tafuri W.L. Evaluation of chemotherapy with benznidazole and itraconazole in mice infected with different Trypanosoma cruzi clonal genotypes. Mem. Inst. Oswaldo Cruz. 95:2000;314.
34. Umezawa E.U., Levy A.M.A., Galvão L.M.C., Gomes L.M., Shikanai-Yasuda M.A., Luquetti A.O. O Papel da sorohogia em pacientes chagásicos submetidos à quimioterapia anti-Trypanosoma cruzi. Rev. Soc. Bras. Med. Trop. 32:1999;80.
35. Veloso V.M., Carneiro C.M., Toledo M.J.O., Lana M., Chiari E., Tafuri W.L., Bahia M.T. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains. Mem. Inst. Oswaldo Cruz. 96:2001;1005-1011.
36. Viotti R., Vigliano C., Armenti H., Segura E. Treatment of chronic Chagas' disease with long-term follow-up. Am. Heart J. 127:1994;151-162.
37. Voller A., Bidwell D.E., Bartlett A. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull. WHO. 53:1976;55-65.
38. Wincker P., Britto C., Pereira J.B., Cardoso M.A., Oelemann W., Morel C.M. Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. Am. J. Trop. Med. Hyg. 51:1994;771-777.